| Name
|
[Tyr1,DPhe2] GHRF (1-29), N-Acetyl, amide
|
| Code
|
[93942-91-7]
|
| The alias
|
[Tyr1,DPhe2] GHRF (1-29), N-Acetyl, amide
|
| Sequence (single letter abbreviation)
|
Ac-Y-DPhe-DAIFTNSYRKVLGQLSARKLLQDIMSR-NH2
|
| Sequence (three-letter abbreviation)
|
Ac-Tyr-DPhe-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2(trifluoroacetate salt)
|
| A basic description
|
VIP receptor antagonist.
|
| solubility
|
|
| The molecular weight
|
3476.1
|
| Chemical formula
|
C157H252N44O43S1
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Weelbroeck et al., Endocrinology, 116, 2643 (1985)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|